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Enantioselectively	functionalised	phenytoin	derivatives	by	
auxiliary-directed	N	to	C	aryl	migration	in	lithiated	α-amino	
nitriles	
Josep	Mas-Roselló,a	Mary	Okoha	and	Jonathan	Clayden*a	
Lithiation	 of	 N’-arylureas	 derived	 from	 amino	 nitriles	
incorporating	a	(1R,	2R)-2-aminocyclohexanol	chiral	auxiliary	leads	
to	diastereoselective	migration	of	the	aryl	ring	to	the	position	α 	to	
the	 nitrile.	 The	 resulting	N'-lithiated	 ureas	 undergo	 spontaneous	
cyclisation	 to	 iminohydantoins,	which	may	be	hydrolysed	 to	give	
chiral	 5,5-diarylhydantoins	 related	 to	 phenytoin,	 in	
enantioenriched	form.	
α-Aryl	 quaternary	 amino	 acid	 motifs	 form	 components	 of	
several	biologically	active	compounds,	especially	in	the	form	of	
their	 5,5-diaryl	 hydantoin	 derivatives	 (Scheme	 1a).[1]	 In	
addition	 to	 this,	 the	 role	 of	 this	 motif	 in	 controlling	 the	
conformation	of	peptidomimetics[2]	makes	 the	stereoselective	
α-arylation	of	amino	acids	an	important	synthetic	challenge.	A	
number	 of	 approaches	 have	 been	 taken	 towards	 this	 aim,	
typically	 using	 SNAr	 reactivity	 of	 highly	 electrophilic	 aryl	 rings	
or	 arynes	 towards	 nucleophilic	 enolate	 equivalents.[2b,3]	
Nonetheless,	 the	 stereoselective	 arylation	 of	 phenylglycine	
and	 other	 arylglycines[4]	 remains	 an	 unsolved	 problem,	 with	
the	 few	 reported	 routes	 to	 chiral	 α,α-diaryl	 glycines	 being	
characterized	 by	 diminished	 stereoselectivity	 or	 reactivity	
relative	to	their	α-alkyl	tertiary	amino	acid	counterparts.[3-5]		
	 One	approach	to	the	arylation	of	α-amino	acids	entails	the	
use	 of	 an	 unusual	 electronically	 unactivated	 Smiles-like	
rearrangement	 that	 takes	 place	 within	 anionic	 or	
organometallic	 derivatives	 of	 N’-aryl	 ureas.[2b,3a,3b,6,7]	 We	
showed	for	example	that	the	urea	derivatives	of	amino	nitriles	
1,	when	deprotonated,	undergo	racemic	 intramolecular	N'→C	
aryl	 transfer	to	2,	 leading	to	arylated	 iminohydantoins	3	after	
spontaneous	 cyclisation.[7]	 Similar	 rearrangements	 of	
aminoamides	 and	 aminoesters	 have	 been	 rendered	
asymmetric	 by	 the	 use	 of	 chiral	 auxiliaries[2b,3a]	 or	 chiral	
memory,[3b]	 but	 these	 reactions	 failed	 to	 give	 products	when	
highly	hindered	substrates	such	as	phenylglycine	were	used	as	
starting	 materials.	 We	 envisaged	 that	 the	 incorporation	 of	 a	
chiral	 auxiliary	as	R2	 in	phenylglycine-derived	amino	nitriles	1	
having	 an	 aromatic	 substituent	 R1	 might	 enable	 a	
diastereoselective	arylation	of	ureas	1,	thereby	giving	access	to	
enantiomerically	 enriched	 iminohydantoins	 3	 (Scheme	 1b).[8]	
These	 are	 immediate	 precursors	 of	 both	 hydantoins	 4	 and	
amino	 acids	 5,	 which	 may	 be	 revealed	 by	 hydrolysis.[9]	 The	
method	 would	 furthermore	 be	 independent	 of	 the	
configuration	of	 the	amino	acid	moiety,	making	 it	particularly	
applicable	 to	 non-proteinogenic	 amino	 acids	 such	 as	
phenylglycines.	
	
Scheme	1.	(a)	Bioactive	α-aryl	quaternary	amino	acids	and	hydantoin	derivatives;	(b)	A	
published	method	for	the	synthesis	of	α-aryl	quaternary	amino	acids	and	hydantoins	by	
intramolecular	arylation	of	aminonitrile	ureas	1.	
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In	order	to	explore	this	proposal	with	an	amino-acid	derivative	
bearing	'unnatural'	substituents,	a	trial	urea	6a	was	made	as	a	
1:1	mixture	 of	 diastereoisomers	 from	 optically	 pure	 (R)-1-(4-
methoxyphenyl)ethylamine	 in	 a	 3	 step	 sequence	 involving	 a	
Strecker	 reaction,[10]	 N-phosgenation	 of	 the	 resulting	
aminonitrile,	 and	 urea	 coupling	 with	 N-methylaniline.	 The	
generality	 and	 simplicity	 of	 this	 Strecker	 approach	 to	 the	
starting	 materials	 illustrates	 a	 further	 advantage	 of	 using	
amino	nitriles	 substituted	 at	 this	 position.	 Initial	 optimisation	
of	 the	 arylation	 reaction	 was	 carried	 out	 using	 this	 furan-
substituted	 nitrile	 6a	 (Table	 1).	 Several	 different	 bases	
deprotonated	 the	 starting	 material	 α	 to	 the	 nitrile	 function	
and	promoted	rearrangement	and	cyclisation	to	the	α-arylated	
iminohydantoin	 product	 7a,	 generally	 in	 good	 yield.	 sec-BuLi	
gave	poor	selectivity	(entries	1,2),	and	among	the	other	bases	
LDA	 performed	 best,	 with	 optimal	 yield	 and	 selectivity	 being	
obtained	in	the	absence	of	an	additive:	entry	7	shows	a	yield	of	
93%	with	77:23	dr.	
Table	1.	Optimisation	of	reaction	conditions	using	6a.	
	
Entry Base[a] Additive t /h, T / °C 7a yield /%[b] (dr)[b,c] 
1 sec-BuLi DMPU[d] 16, –50 88 (57:43) 
2 LDA DMPU[d] 6, 0 90 (67:33) 
3 LDA LiCl[e] 6, 0 83 (74:26)[f] 
4 LDA LiCl[e] 3, rt 91 (76:24) 
5 LiTMP LiCl[e] 3, rt 76 (75:25) 
6 LiHMDS LiCl[e] 16, rt 90 (74:26) 
7 LDA - 3, rt 93[g] (77:23) 
8 KHMDS - 12, rt 86 (67:33) 
[a]	Base	(2.0	equiv.	added	to	6a	in	THF).	[b]	Yield	and	dr	determined	by	1H	NMR	
of	the	crude	reaction	mixture	using	hexamethylbenzene	as	internal	standard.	[c]	
Absolute	 configuration	 of	 new	 stereogenic	 centre	 not	 determined.	 [d]	DMPU	=	
1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone,	10%	v/v.	 [e]	4	equiv.	of	dry	
LiCl	 added.	 [f]	 7%	 6a	 recovered	 as	 a	 50:50	 mixture	 of	 diastereoisomers.	 [g]	
Isolated	yield	of	a	mixture	of	diastereoisomers	in	a	65:35	ratio.	
The	next	challenge	was	to	 increase	the	diastereoselectivity	of	
the	 reaction.	 A	 series	 of	 substrates	 6b-6e	 were	 made	 as	
diastereoisomeric	mixtures	 from	enantiopure	primary	 amines	
(H2N–R
2;	 highlighted	 in	 green)	by	 the	 Strecker	 route	used	 for	
6a	 (Scheme	2).	 Substrates	6b-c	 containing	 chiral	 amines	with	
additional	 metal-coordinating	 sites[11]	 were	 detrimental	 for	
both	 selectivity	 and	 yield.	 Protection	 of	 the	 free	 hydroxyl	
group	 of	 6c	 in	 the	 form	 of	 the	 O-tert-butyl(dimethyl)silyl	
derivative	6d	 led	to	an	 increase	 in	dr.	Finally,	 the	 less	 flexible	
trans-2-aminocyclohexanol-derived	substrate	6e	turned	out	to	
be	the	most	selective	by	far,	giving	the	iminohydantoin	7e	with	
a	 diastereoselectivity	 of	 >95:5.	 Repeating	 the	 reaction	 with	
both	 diastereosiomers	 individually	 gave	 the	 same	 selectivity.	
Trans-2-aminocyclohexanol	has	been	used	as	a	chiral	auxiliary	
or	 chiral	 ligand	 in	 a	 number	 of	 other	 reactions,[12]	 and	 both	
enantiomers	are	commercially	available	and	equally	accessible	
on	 scale	 from	 amination	 of	 the	 corresponding	 meso	
epoxide.[12,13]	The	auxiliary	may	be	easily	removed	under	acidic	
conditions	by	dehydration	–	enamide	hydrolysis.	
	
Scheme	2.	 	 Screening	chiral	amines	as	auxiliaries.	2	equiv	 LDA	used	unless	otherwise	
indicated.	Diastereoisomeric	ratios	determined	by	1H	NMR	of	crude	reaction	mixtures.	
[a]	Absolute	configuration	of	new	stereogenic	centre	not	determined.	[b]	3	equiv	LDA.	
[c]	 Yield	 from	 diastereoisomer	 1.	 [d]	 Absolute	 configuration	 of	7e	 (Ph	 ring	migrates)	
assigned	as	shown	by	analogy	to	9b	(see	below).	[e]	Yield	from	diastereoisomer	2.		
Extension	of	the	highly	diastereoselective	rearrangement	of	6e	
to	 other	 substrates	 would	 constitute	 a	 method	 for	 the	
synthesis	 of	 enantiomerically	 enriched	 5,5-diaryl	 hydantoins	
related	 to	 the	 anti-convulsant	 drug	 phenytoin,	 selectively	
functionalised	 on	 one	 of	 the	 two	 phenyl	 rings.[14]	 Such	
enantioselectively	 functionalised	 structures	 have	 found	
extensive	in	explorations	of	mechanisms	of	biological	oxidation	
of	 this	 drug,	 but	 have	 been	 previously	 accessible	 in	
enantiopure	 form	 only	 by	 resolution.[15]	 To	 explore	 the	
application	 of	 the	 diastereoselective	 arylation	 to	 the	
asymmetric	synthesis	of	phenytoin	derivatives	and	other	chiral	
5,5-diarylhydantoins,	we	made	a	 series	of	 ureas	8a-e	 bearing	
the	 optimal	 silylated	 (1R,	 2R)-aminocyclohexanol	 auxiliary	
using	the	Strecker-type	protocol	employed	for	the	synthesis	of	
6a-e	(see	supporting	information).	
	 A	pair	of	diastereoisomeric	4-	and	4'-methylated	phenytoin	
derivatives	was	made	by	migrating	respectively	a	phenyl	group	
to	 the	α-position	 of	 the	p-tolyl	 substituted	 urea	 8a	 and	 a	 p-
tolyl	group	to	the	α-position	of	the	phenyl	substituted	urea	8b.	
Both	 reactions	 proceeded	 with	 excellent	 diastereoselectivity,	
and	gave	phenytoin	derivatives	9a	and	9b	of	opposite	absolute	
configuration	at	 the	quaternary	 centre.	On	 the	basis	 that	 the	
new	stereogenic	centre	of	9b	has	S	 configuration	 (see	below)	
we	 deduce	 that	 the	 (1R,	 2R)-aminocyclohexanol	 induced	
migration	 to	 the	 Si	 face	 of	 the	 intermediate	 enolate.	 The	
phenyl	 group	 migrated	 in	 this	 intramolecular	 SNAr	 reaction	
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somewhat	more	readily	than	the	p-tolyl	group,	which	required	
DMPU	 as	 co-solvent	 and	 heating	 to	 +40	 °C	 to	 reach	
completion.	
	 A	 second	 pair	 of	 diastereoisomeric	 fluorinated	 phenytoin	
derivatives	 was	made	 by	migrating	 either	 the	 4-fluorophenyl	
group	 of	 8c	 or	 the	 phenyl	 group	 of	 8d,	 giving	 the	
enantioselectively	fluorinated	derivatives	9c	and	9d.	Again	the	
substituted	 4-fluorophenyl	 ring	 required	 more	 forcing	
conditions	to	migrate.	
	 This	 diastereoselective	 arylation	 is	 of	 particular	 strategic	
value	 for	 the	 synthesis,	 in	 an	 enantioselective	 manner,	 of	
diaryl	 glycine	 derivatives	 in	 which	 the	 aryl	 rings	 are	 only	
minimally	 different,	 and	 would	 therefore	 be	 impossible	 to	
resolve	 using	 standard	 techniques.	 Illustrating	 this	 point,	
migration	 of	 the	 2,3,4,5,6-pentadeuterophenyl	 ring	 to	 the	
phenyl-bearing	nitrile	substrate	8e	gave	a	product	in	which	the	
phenytoin	moiety	is	enantioselectively	deuterated	in	only	one	
of	the	two	rings.[16]	
	
Scheme	 3.	 Asymmetric	 synthesis	 of	 phenytoin	 derivatives.	 DMPU	 =	 1,3-dimethyl-
3,4,5,6-tetrahydro-2(1H)-pyrimidinone.	 [a]	 Method	 A;	 [b]	 Method	 B;	 [c]	
Diastereoisomeric	 ratio	 established	by	 the	 relative	 integration	of	 the	 two	quaternary	
carbon	signals	showing	HMBC	correlations	to	a	protonated	(ie,	non-deuterated)	phenyl	
ring.	[d]	Using	Method	A	but	left	to	stir	overnight.		
Transformation	 of	 the	 diaryl	 iminohydantoins	 9	 into	 the	
valuable	 hydantoin	 products	 10	 was	 achieved	 by	 a	 two-step	
hydrolysis	 process	 in	 which	 the	 iminohydantoin	 was	 first	
desilylated	 and	 converted	 to	 a	 hydantoin	 and,	 and	 then	 in	 a	
second	 step	 the	 auxiliary	 removed.	 Scheme	 4	 shows	 this	
proves	 for	 the	 iminohydantoin	 9b.	 Acidic	 hydrolysis	 with	 2M	
HCl	in	MeOH	yielded	O-desilylated	hydantoin	10b	in	high	yield.	
Cleavage	 of	 the	 chiral	 auxiliary	 by	 heating	 in	 neat	
polyphosphoric	 acid	 afforded	 enantioenriched	 hydantoin	 11b	
in	52%	yield	with	95:5	er.	The	absolute	configuration	of	(S)-11b	
was	determined	by	comparison	of	its	HPLC	retention	time	on	a	
chiral	 stationary	 phase	 with	 that	 of	 an	 authentic	 sample[17]	
(see	SI	for	further	details).	
	
Scheme	4.	Conversion	of	products	into	enantioenriched	C-diaryl	hydantoins.		
The	 mechanism	 by	 which	 the	 intramolecular	 arylation	 takes	
place	 is	 an	 unactivated	 Smiles-like	 rearrangement[18]	 induced	
by	the	well-defined	conformation[19]	of	the	N-aryl	urea.[20]	This	
family	of	reactions	do	not	require	electron-withdrawing	groups	
for	success,[3a,3b,6a,6b,7,9]	and	appear	to	proceed	by	a	single	step	
pathway	without	a	Meisenheimer	intermediate.[20,21]	
	 In	 summary,	 the	 diastereoselective	 intramolecular	 C-
arylation	of	α-amino	nitrile	derivatives	of	phenylglycines	gives,	
with	high	 levels	of	 stereoselectivity,	α,α-diarylated	hydantoin	
detivatives.	 The	 reaction	 was	 applied	 to	 the	 synthesis	 of	
fluorinated	and	deuterated	derivatives	of	the	drug	phenytoin,	
of	 value	 in	 drug	 metabolism	 and	 pharmacokinetics	 studies,	
producing	 these	 derivatives	 with	 excellent	 yields	 and	
stereoselectivities.	
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One	sentence	summary:	
	
A	 'non-classical'	 diastereoselective	 intramolecular	 SNAr	
reaction	 allows	 the	 construction	 of	 chiral	 diarylglycine	
derivatives	in	the	form	of	hydantoins	related	to	phenytoin	
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